Search

Stryker buys VC-backed medical device company Arrinex

Updated: Mar 1, 2019




PRESS RELEASE

Kalamazoo, Michigan, Feb. 25, 2019 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix®, a novel cryoablation technology for the treatment of chronic rhinitis.

This condition, which affects over 24 million people in the U.S. each year, may cause runny nose, congestion, sneezing and nasal itching. Arrinex, which was founded in 2013, began commercializing ClariFix in late 2017 in the U.S. ClariFix further expands Stryker’s Ear, Nose and Throat (ENT) portfolio with a unique product to address a large, underpenetrated segment of the ENT market where Stryker does not currently compete.


Read more.


source pe hub network

7 views

Recent Posts

See All
Contact
  • LinkedIn Social Icon

© 2020 IntMeDA